首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1550544

注射市場：依分子類型、給藥途徑、治療領域、藥物類別、通路和地區

Injectable Drugs Market, By Molecule Type, By Route of Administration, By Therapeutic Area, By Drug Class, By Distribution Channel, By Geography

出版日期: 2024年08月20日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球注射劑市場規模為5,701.1億美元，2031年將達9,460.9億美元，2024年至2031年複合年成長率為7.5%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	5701.1億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	7.50%	2031年價值預測	9460.9億美元

圖：2024 年按地區分類的注射劑市場佔有率(%)

注射劑主要是指經由靜脈、肌肉或組織直接注射到體內的藥物。由於藥物輸送可以將藥物直接輸送到血流中，因此在各種重症加護治療中它比其他藥物傳輸方法更受青睞。藥物傳遞技術的進步導致了新型注射製劑的開發，其活性成分的穩定性、溶解度和生物有效性得到了改善。慢性病盛行率的增加、對生技藥品和標靶藥物治療的日益關注以及對自我注射注射劑的需求不斷成長可能會推動市場成長。

市場動態：

全球注射劑市場的成長是由癌症、糖尿病和自體免疫疾病等慢性病盛行率上升所推動的。據世界衛生組織稱，慢性病估計佔全球死亡人數的 60% 以上。治療癌症和自體免疫疾病的生技藥品和標靶藥物療法的快速採用也推動了市場成長。然而，注射劑的研究、開發和製造成本高昂，可能會對市場相關人員造成挑戰。注射注射劑時被針刺傷的風險也可能阻礙其廣泛使用。對自我管理注射劑的需求不斷成長，特別是對慢性病管理的需求，可能在不久的將來提供成長機會。

本研究的主要特點

本報告對全球注射藥品市場進行了詳細分析，並給出了以2023年為基準年的預測期（2024-2031）的市場規模和年平均成長率。

它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數，包括全球注射劑市場主要企業的概況。

主要企業包括輝瑞、諾華、賽諾菲、葛蘭素史克、吉利德科學和艾伯維。

本報告中的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球注射劑市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過用於分析全球注射劑市場的各種策略矩陣來促進他們的決策。

Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi SA
Sun Pharmaceutical Industries Ltd.
AstraZeneca Plc
Merck & Co., Inc.
Viatris+Mylan NV
Cipla Inc.
Dr Reddy's Laboratories Ltd.
Samsung Biologics
Abbott Laboratories
Amgen Incorporated
Baxter International Incorporated
Becton Dickinson and Company
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Roche Holding Limited

第11章分析師建議

命運之輪
分析師觀點
一致的機會圖

第12章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI5378

Global injectable drugs market is estimated to be valued at USD 570.11 Billion in 2024 and is expected to reach USD 946.09 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 570.11 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.50%	2031 Value Projection:	US$ 946.09 Bn

Figure. Injectable Drugs Market Share (%), By Region 2024

Injectable drugs refer to medications that are administered directly into the body, mostly through veins, muscles or tissues. These are preferred over other drug delivery methods for various critical care therapies, owing to their ability to deliver medications directly into the bloodstream, ensuring rapid onset of action. Advancements in drug delivery technologies have led to development of novel injectable formulations with improved stability, solubility and bioavailability of active pharmaceutical ingredients. Growing prevalence of chronic diseases, rising focus on biologics and targeted drug therapies, and increasing demand for self-administered injectables can drive the market growth.

Market Dynamics:

Global injectable drugs market growth is driven by rising prevalence of chronic diseases such as cancer, diabetes and autoimmune disorders. According to WHO, chronic diseases are estimated to account for over 60% of global deaths. Rapid adoption of biologics and targeted drug therapies for treatment of cancer and autoimmune diseases can also drive the market growth. However, high costs associated with R&D and manufacturing of injectable products can pose challenges for the market players. Risk of needle-stick injuries while administering injectables can also hamper its adoption. Growing demand for self-administered injectables especially for management of chronic diseases can offer growth opportunities in the near future.

Key features of the study:

This report provides in-depth analysis of the global injectable drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global injectable drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Novartis, Sanofi, GlaxoSmithKline, Gilead Sciences and AbbVie

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drugs market

Detailed Segmentation-

By Molecule Type Insights (Revenue, USD Bn, 2019 - 2031)
- Small Molecule
- Large Molecule
By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Intravenous
- Intramuscular
- Subcutaneous
- Others (Intradermal etc.)
By Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2031)
- Oncology
- Infectious Diseases
- Autoimmune Disorders
- Cardiovascular Diseases
- Endocrinology
- Neurology
- Others (Respiratory, Hematology, etc.)
By Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
- Monoclonal Antibodies
- Peptides and Proteins
- Small Molecules
- Immunoglobulins
- Hormones
- Others (Vaccines, Biologics, etc.)
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- AstraZeneca Plc
- Merck & Co., Inc.
- Viatris + Mylan N.V
- Cipla Inc.
- Dr Reddy's Laboratories Ltd.
- Samsung Biologics
- Abbott Laboratories
- Amgen Incorporated
- Baxter International Incorporated
- Becton Dickinson and Company
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Roche Holding Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Injectable Drugs Market, By Molecule Type
- Global Injectable Drugs Market, By Route of Administration
- Global Injectable Drugs Market, By Therapeutic Area
- Global Injectable Drugs Market, By Drug Class
- Global Injectable Drugs Market, By Distribution Channel
- Global Injectable Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Injectable Drugs Market, By Molecule Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Large Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Injectable Drugs Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Intradermal etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Injectable Drugs Market, By Therapeutic Area, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Respiratory, Hematology, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Injectable Drugs Market, By Drug Class, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Peptides and Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Small Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Vaccines, Biologics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Injectable Drugs Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Injectable Drugs Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020- 2031, (USD Bn)
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
AstraZeneca Plc
Merck & Co., Inc.
Viatris + Mylan N.V
Cipla Inc.
Dr Reddy's Laboratories Ltd.
Samsung Biologics
Abbott Laboratories
Amgen Incorporated
Baxter International Incorporated
Becton Dickinson and Company
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Roche Holding Limited